norm: forte biosciencesNAICS Pharmaceutical Preparations · USno LEI · CIK 0001419041Max severity: Low

Canonical registry

Forte Biosciences, Inc.

ent_019fa1fd95cfcec0a1dfc9d779b32c07

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Forte Biosciences, Inc.
Normalized: forte biosciences— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001419041
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-03-31
Item 1C of Form 10-K describes the registrant's cybersecurity risk management and oversight processes. The filing details the use of third-party consultants, technical controls (encryption, patching, access controls), and Board/Audit Committee oversight. No specific cybersecurity incident, breach, or material impact is disclosed.